ArticleCureus2025
Readmissions in Inflammatory Bowel Diseases: A Five-Year Retrospective Study in a Romanian Emergency County Hospital.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHospital readmissions represent a significant problem in the management of chronic diseases, provoking a substantial burden both on patients and the national healthcare system. Chronic diseases such as chronic obstructive pulmonary disease, diabetes mellitus, heart failure, and liver cirrhosis have documented risk factors, and guidelines are being continuously developed for reducing readmissions. Despite advancements, readmission patterns in some chronic conditions still remain underexplored. Recurrent hospitalizations among inflammatory bowel disease (IBD) patients may reflect disease severity, frequency of complications, and inadequate outpatient management, which can negatively impact quality of life and increase financial strain on healthcare systems. This study aimed to characterize readmission frequency, timing, and causes in Crohn's disease (CD) vs ulcerative colitis (UC) patients over a five-year period, and to identify factors associated with readmissions.
methodsWe conducted a retrospective cohort study at the Târgu Mureș Emergency Clinical County Hospital using electronic records from 2018 to 2023. Adult patients discharged with a diagnosis of CD or UC were identified by International Classification of Diseases, 10th Revision (ICD-10) coding. Data collected included IBD subtype, number of admissions per patient, time intervals between admissions, presenting symptoms, admitting department, and in-hospital complications. Descriptive statistics were performed to compare CD and UC outcomes.
resultsA total of 79 IBD patients accounted for 198 hospital admissions. Of these, 32 (41%) patients had CD and 47 (59%) had UC. CD patients experienced significantly more frequent readmissions, with a shorter mean interval between admissions (172 days for CD vs 487 days for UC, p<0.01). Length of stay per admission was similar between groups (p=0.18). The most common presentation reasons that led to admission in CD were abdominal pain (52 cases, 55%), rectorrhagia (35 cases, 37%), and fever (35 cases, 37%), whereas in UC they were abdominal pain (65 cases, 63%), diarrhea (48 cases, 46%), and rectorrhagia (27 cases, 26%). The majority of admissions in both groups were to the Gastroenterology department (CD: 41 cases (44%), UC: 58 cases (56%)) or surgery (CD: 35 cases (37%), UC: 31 cases (30%)), with a minority to Internal Medicine (CD: 4 cases (4%), UC: 7 cases (7%)) or other services. Key complications differed: CD patients had high rates of perianal abscesses (6 cases, 18%) and fistulas (1 case, 4%), while UC patients more frequently developed intestinal obstruction/occlusion (8 cases, 17%) or hemorrhoids (3 cases, 6%).
conclusionIBD readmissions are common, with CD patients prone to earlier and more frequent hospital returns than UC patients, likely due to more frequent disease relapses and complications. Both groups often present with severe symptoms (pain, bleeding) necessitating acute care. Our findings underscore the need for proactive strategies, including optimizing outpatient management and addressing modifiable risk factors such as psychiatric comorbidities, corticosteroid use, and
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.